Skip to main content

Peer Review reports

From: A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer

Original Submission
21 Jul 2016 Submitted Original manuscript
30 Apr 2017 Reviewed Reviewer Report - Omer Kucuk
25 May 2017 Reviewed Reviewer Report - Howard Gurney
21 Jul 2017 Author responded Author comments - Hae Su Kim
Resubmission - Version 2
21 Jul 2017 Submitted Manuscript version 2
25 Jul 2017 Author responded Author comments - Hae Su Kim
Resubmission - Version 3
25 Jul 2017 Submitted Manuscript version 3
3 Aug 2017 Author responded Author comments - Hae Su Kim
Resubmission - Version 4
3 Aug 2017 Submitted Manuscript version 4
Publishing
11 Aug 2017 Editorially accepted
22 Aug 2017 Article published 10.1186/s12894-017-0253-z

You can find further information about peer review here.

Back to article page